Role of Insulin Resistance and Hyperglycemia in the Development of Atherosclerosis

American Journal of Cardiology

Volumn 99, Issue 4 SUPPL., 2007, Pages 6-14

  Bansilal, Sameer ^a   Farkouh, Michael E ^a   Fuster, Valentin ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANGIOTENSINOGEN; GLUCOSE; INSULIN RECEPTOR; LEPTIN; LIPID; PHOSPHATIDYLINOSITOL 3 KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DISEASE COURSE; DISEASE PREDISPOSITION; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; GLUCOSE HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; IMMUNE RESPONSE; INFLAMMATORY CELL; INSULIN RESISTANCE; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ADIPOSE TISSUE; ANIMALS; CORONARY ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; RECEPTOR, INSULIN; T-LYMPHOCYTES;

EID: 33846923177     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.11.002     Document Type: Article

References (38)

1. Reaven G.M. 1988 Banting lecture: role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
2. Hanley A.J., Williams K., Stern M.P., and Haffner S.M. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25 (2002) 1177-1184
3. Bonora E., Formentini G., Calcaterra F., Lombardi S., Marini F., Zenari L., Saggiani F., Poli M., Perbellini S., Raffaelli A., et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 25 (2002) 1135-1141
4. Howard G., O'Leary D.H., Zaccaro D., Haffner S., Rewers M., Hamman R., Selby J.V., Saad M.F., Savage P., and Bergman R. Insulin sensitivity and atherosclerosis: the Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 93 (1996) 1809-1817
5. Stary H.C., Chandler A.B., Dinsmore R.E., Fuster V., Glagov S., Insull Jr. W., Rosenfeld M.E., Schwartz C.J., Wagner W.D., Wissler R.W., and American Heart Association. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Atherosclerosis. Arterioscler Thromb Vasc Biol 15 (1995) 1512-1531
6. Fuster V., Moreno P.R., Fayad Z.A., Corti R., and Badimon J.J. Atherothrombosis and high-risk plaque. Part I. Evolving concepts. J Am Coll Cardiol 46 (2005) 937-954
7. Nigro J., Osman N., Dart A.M., and Little P.J. Insulin resistance and atherosclerosis. Endocr Rev 27 (2006) 242-259
8. Hsueh W.A., and Law R. The central role of fat and effect of peroxisome proliferator-activated receptor-γ on progression of insulin resistance and cardiovascular disease. Am J Cardiol 92 suppl (2003) 3J-9J
9. Haffner S.M. Insulin resistance, inflammation and the prediabetic state. Am J Cardiol 92 suppl (2003) 18J-26J
10. DeFronzo R.A. Is insulin resistance atherogenic?. Possible mechanisms. Atheroscler Suppl 7 (2006) 11-15
11. Pittas A.G., Joseph N.A., and Greenberg A.S. Adipocytokines and insulin resistance. J Clin Endocrinol Metab 89 (2004) 447-452
12. Lyon C.J., Law R.E., and Hsueh W.A. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144 (2003) 2195-2200
13. Piemonti L., Calori G., Mercalli A., Lattuada G., Monti P., Garancini M.P., Costantino F., Ruotolo G., Luzi L., and Perseghin G. Fasting plasma leptin, tumor necrosis factor-α receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose tolerant and glucose-intolerant women: impact on cardiovascular mortality. Diabetes Care 26 (2003) 2883-2889
14. Andreozzi F., Laratta E., Sciacqua A., Perticone F., and Sesti G. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells. Circ Res 94 (2004) 1211-1218
15. Bruun J.M., Verdich C., Toubro S., Astrup A., and Richelsen B. Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-α: effect of weight loss in obese men. Eur J Endocrinol 148 (2003) 535-542
16. Festa A., D'Agostino Jr. R., Tracy R.P., and Haffner S.M. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 51 (2002) 1131-1137
17. Romano M., Guagnano M.T., Pacini G., Vigneri S., Falco A., Marinopiccoli M., Manigrasso M.R., Basili S., and Davi G. Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J Clin Endocrinol Metab 88 (2003) 5321-5326
18. Zeng G., Nystrom F.H., Ravichandran L.V., Cong L.N., Kirby M., Mostowski H., and Quon M.J. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101 (2000) 1539-1545
19. Kuboki K., Jiang Z.Y., Takahara N., Ha S.W., Igarashi M., Yamauchi T., Feener E.P., Herbert T.P., Rhodes C.J., and King G.L. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 101 (2000) 676-681
20. Liu W., Liu Y., and Lowe Jr. W.L. The role of phosphatidylinositol 3-kinase and the mitogen-activated protein kinases in insulin-like growth factor-I-mediated effects in vascular endothelial cells. Endocrinology 142 (2001) 1710-1719
21. Hu R.M., Levin E.R., Pedram A., and Frank H.J. Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes 42 (1993) 351-358
22. Kim J.A., Montagnani M., Koh K.K., and Quon M.J. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113 (2006) 1888-1904
23. Banskota N.K., Taub R., Zellner K., Olsen P., and King G.L. Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I. Diabetes 38 (1989) 123-129
24. Imai Y., and Clemmons D.R. Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyribonucleic acid synthesis by insulin-like growth factor-I. Endocrinology 140 (1999) 4228-4235
25. Wang C.C., Gurevich I., and Draznin B. Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. Diabetes 52 (2003) 2562-2569
26. Bar R.S., Gorden P., Roth J., Kahn C.R., and De Meyts P. Fluctuations in the affinity and concentration of dieting insulin receptors on circulating monocytes of obese patients: effects of starvation and refeeding. J Clin Invest 58 (1976) 1123-1135
27. Soman V.R., and DeFronzo R.A. Direct evidence for downregulation of insulin receptors by physiologic hyperinsulinemia in man. Diabetes 29 (1980) 159-163
28. Liang C.P., Han S., Okamoto H., Carnemolla R., Tabas I., Accili D., and Tall A.R. Increased CD36 protein as a response to defective insulin signaling in macrophages. J Clin Invest 113 (2004) 764-773
29. Sampson M.J., Davies I.R., Braschi S., Ivory K., and Hughes D.A. Increased expression of a scavenger receptor (CD36) in monocytes from subjects with type 2 diabetes. Atherosclerosis 167 (2003) 129-134
30. Iida K.T., Suzuki H., Sone H., Shimano H., Toyoshima H., Yatoh S., Asano T., Okuda Y., and Yamada N. Insulin inhibits apoptosis of macrophage cell line, THP-1 cells, via phosphatidylinositol-3-kinase-dependent pathway. Arterioscler Thromb Vasc Biol 22 (2002) 380-386
31. Hansson G.K., Holm J., and Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 135 (1989) 169-175
32. Rosen P., Nawroth P.P., King G., Moller W., Tritschler H.J., and Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a congress series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 17 (2001) 189-212
33. Basta G., Schmidt A.M., and De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63 (2004) 582-592
34. Kirstein M., Brett J., Radoff S., Ogawa S., Stern D., and Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci U S A 87 (1990) 9010-9014
35. Wendt T., Harja E., Bucciarelli L., Qu W., Lu Y., Rong L.L., Jenkins D.G., Stein G., Schmidt A.M., and Yan S.F. RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis 185 (2006) 70-77
36. Vischer U.M. Hyperglycemia and the pathogenesis of atherosclerosis: lessons from murine models. Eur J Endocrinol 140 (1999) 1-3
37. Quagliaro L., Piconi L., Assaloni R., Da Ros R., Maier A., Zuodar G., and Ceriello A. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 183 (2005) 259-267
38. Buse M.G. Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol 290 (2006) E1-E8